Compare DUOL & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DUOL | BCPC |
|---|---|---|
| Founded | 2011 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.3B |
| IPO Year | 2021 | 1995 |
| Metric | DUOL | BCPC |
|---|---|---|
| Price | $142.86 | $177.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $176.69 | $176.00 |
| AVG Volume (30 Days) | ★ 1.3M | 158.2K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ 355.85 | 20.87 |
| EPS | 1.53 | ★ 2.63 |
| Revenue | ★ $1,037,589,000.00 | $799,023,000.00 |
| Revenue This Year | $18.93 | $8.47 |
| Revenue Next Year | $14.02 | $4.89 |
| P/E Ratio | $92.08 | ★ $68.36 |
| Revenue Growth | ★ 38.71 | 13.56 |
| 52 Week Low | $87.89 | $139.17 |
| 52 Week High | $353.00 | $183.90 |
| Indicator | DUOL | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 58.00 |
| Support Level | $142.10 | $159.54 |
| Resistance Level | $151.00 | $182.99 |
| Average True Range (ATR) | 7.18 | 3.55 |
| MACD | 0.18 | -0.33 |
| Stochastic Oscillator | 61.83 | 50.47 |
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated, master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue: time-based subscriptions, in-app advertising placement by third parties, the Duolingo English Test, and In-App purchases. Geographically, the company generates revenue from its customers in the United States and other markets.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.